Cibc Private Wealth Group, LLC Charles River Laboratories International, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 153,467 shares of CRL stock, worth $25.3 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
153,467
Previous 153,062
0.26%
Holding current value
$25.3 Million
Previous $31.6 Million
4.39%
% of portfolio
0.06%
Previous 0.06%
Shares
25 transactions
Others Institutions Holding CRL
# of Institutions
691Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$838 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$616 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$351 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$320 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.38B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...